Outlook Therapeutics Inc (OTLK)

[H2R]

1 more site -> 56 as of April 24th

-> Lenexa, Kansas, United States, 66215

I also pay attention to the completion dates. They have not moved since the first version on clinical trials. They are:

* Primary Completion: September 2024 [Anticipated]
* Study Completion: October 2024 [Anticipated]

with the resubmittal planned by the end of the year. Even if it moved a bit, say January, that's in the ballpark.

At this stage, OTLK must be seeing the current enrollment and continue to plan accordingly. The completion dates can be updated with each new revision. And they keep being the same.

I'm not sure that all 60 planned sites are necessary for the enrollment. It's now 56 recruiting sites out of 60 planned.

And then, there is the end of May European decision.

Best of luck with your investments!